Company Overview
The Group has operated through its holding entity, Anagenics Limited (corporate, operational, and administrative functions) and its two main subsidiary companies, Advangen Pty Limited (consumer health product development and sales) and from October 2021, BLC Cosmetics Pty Limited (a distributor of prestige beauty cosmetics and equipment). With the sale of Lyramid in early 2021 the Group has now completed the transition from biotechnology and research to a full health and beauty tech business. The Group is poised for its next stage of development using the solid building blocks of differentiated brands, global distribution footprint, growing revenue and targeting near term profitability. Other than the acquisition of BLC Cosmetics Pty Limited there were no other substantial changes in the activities of the Group during the reporting period.
| Website | www.cellmid.com.au |
|---|---|
| Head Office | Sydney NSW |
| Registry | Automic Registry Services |
| CEO | Matthew Dudek |
| Chair Person | Alexander (Sandy) Beard |
| GICS Industry | Household & Personal Products |
| Sub Industry | Personal Products |
| Sector | Consumer Staples |
| Market Cap | $5 m |
|---|---|
| Shares on Issue | 249 m |
| Status | Trading |
| Last Price | |
| Change | |
| 52 Week H/L | |
| VWAP | |
| Bid/Ask |
Directors and Management
Top 20 Shareholders
| Name | Shares | % |
|---|
Director Transactions
| Date | Name | Qty | Value | Direction | Notes |
|---|